The Valley Desk

NCT01641640 · Interventional trial

Sofosbuvir With Peginterferon Alfa 2a and Ribavirin for 12 Weeks in Treatment-Naive Subjects With Chronic Genotype 1, 4, 5, or 6 HCV Infection

Overall registry status Completed

Phase 3

Conditions Chronic Hepatitis C

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov